Glucose monitoring for newborns of mothers with insulin-treated diabetes
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study uses a small sensor to continuously monitor blood sugar levels in newborns whose mothers had insulin-treated gestational diabetes. It aims to make sure babies' glucose levels stay healthy after birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are pregnant with one baby (not twins or more).
- You have gestational diabetes that is treated with insulin.
- You did not smoke during this pregnancy.
- You do not have preeclampsia or fetal growth restriction.
- Your baby is born at or after 37 weeks of pregnancy and has no major birth defects, skin problems, or infections at birth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a small sensor that measures blood sugar continuously is accurate in newborn babies. It may help doctors better monitor and care for babies' sugar levels after birth.
This study compares using a continuous glucose monitor (a small sensor that tracks sugar levels all day) with the usual finger-prick testing in women with gestational diabetes. The goal is to see if the monitor helps control blood sugar better and is easier to use.
This study tests a continuous glucose monitor (CGM) in newborns with hypoxic-ischemic encephalopathy (HIE) — a type of brain injury from lack of oxygen around birth. The CGM tracks sugar levels to help doctors manage care better.
This study tests whether using a continuous glucose monitor (a small sensor that checks your blood sugar all day) can improve outcomes for you and your baby during gestational diabetes. It may help you manage your blood sugar more easily and reduce risks.
This study uses a continuous glucose monitor (a small sensor that tracks your blood sugar) after you give birth to see if your blood sugar levels return to normal. It may help detect early signs of type 2 diabetes and guide your postpartum care.
This trial tests how accurate two different continuous glucose monitors (CGMs) are during pregnancy, to help improve diabetes care for pregnant women. By wearing two sensors, they can compare readings and see if they are reliable.
Hear when a new Neonatal Hypoglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.